Cargando…

Mir 145/143: tumor suppressor, oncogenic microenvironmental factor or …both?

Detalles Bibliográficos
Autores principales:	Cioce, Mario, Strano, Sabrina, Muti, Paola, Blandino, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Letters to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931860/ https://www.ncbi.nlm.nih.gov/pubmed/27208668 http://dx.doi.org/10.18632/aging.100965

Ejemplares similares

What biomarkers (if any) for precise medicine?
por: Strano, Sabrina, et al.
Publicado: (2015)

Metformin: Metabolic Rewiring Faces Tumor Heterogeneity
por: Cioce, Mario, et al.
Publicado: (2020)

Epigenetic silencing of miR-145-5p contributes to brain metastasis
por: Donzelli, Sara, et al.
Publicado: (2015)

Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
por: Lo Sardo, Federica, et al.
Publicado: (2017)

Metformin-induced metabolic reprogramming of chemoresistant ALDH(bright) breast cancer cells
por: Cioce, Mario, et al.
Publicado: (2014)

MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancer
por: Canu, Valeria, et al.
Publicado: (2017)

PML Surfs into HIPPO Tumor Suppressor Pathway
por: Strano, Sabrina, et al.
Publicado: (2013)

The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease
por: Vacante, Francesca, et al.
Publicado: (2019)

YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting
por: Lo Sardo, Federica, et al.
Publicado: (2018)

The miR-143/miR-145 cluster and the tumor microenvironment: unexpected roles
por: Almeida, Maria Inês, et al.
Publicado: (2016)

Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma
por: Cioce, Mario, et al.
Publicado: (2021)

Insights into Intra-Tumoral Heterogeneity: Transcriptional Profiling of Chemoresistant MPM Cell Subpopulations Reveals Involvement of NFkB and DNA Repair Pathways and Contributes a Prognostic Signature
por: Cioce, Mario, et al.
Publicado: (2021)

Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention
por: Pulito, Claudio, et al.
Publicado: (2013)

Oncogenic Intra-p53 Family Member Interactions in Human Cancers
por: Ferraiuolo, Maria, et al.
Publicado: (2016)

miR-181c associates with tumor relapse of high grade osteosarcoma
por: Federica, Mori, et al.
Publicado: (2015)

Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma
por: Di Agostino, Silvia, et al.
Publicado: (2018)

Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers
por: Ferraiuolo, Maria, et al.
Publicado: (2017)

HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis
por: Di Agostino, Silvia, et al.
Publicado: (2023)

Regulation of intraocular pressure by microRNA cluster miR-143/145
por: Li, Xinyu, et al.
Publicado: (2017)

miR-145 and miR-143 Regulate Smooth Muscle Cell Fate Decisions
por: Cordes, Kimberly R., et al.
Publicado: (2009)

Epigenetic regulation of MIR145 core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome
por: Pilala, Katerina-Marina, et al.
Publicado: (2022)

MicroRNA-143/-145 in Cardiovascular Diseases
por: Zhao, Wang, et al.
Publicado: (2015)

Expression levels of atherosclerosis-associated miR-143 and miR-145 in the plasma of patients with hyperhomocysteinaemia
por: Liu, Kejian, et al.
Publicado: (2017)

Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects
por: Mori, Federica, et al.
Publicado: (2016)

Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
por: Pulito, Claudio, et al.
Publicado: (2019)

Involvement of Dual Strands of miR-143 (miR-143-5p and miR-143-3p) and Their Target Oncogenes in the Molecular Pathogenesis of Lung Adenocarcinoma
por: Sanada, Hiroki, et al.
Publicado: (2019)

MicroRNAs: short non-coding players in cancer chemoresistance
por: Donzelli, Sara, et al.
Publicado: (2014)

The differential expression of microRNA-143,145 in endometriosis
por: Zheng, Bingbing, et al.
Publicado: (2014)

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer
por: Villadsen, S B, et al.
Publicado: (2012)

Lessons from miR-143/145: the importance of cell-type localization of miRNAs
por: Kent, Oliver A., et al.
Publicado: (2014)

Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer
por: Johannessen, Charles, et al.
Publicado: (2017)

Identification of the canonical and noncanonical role of miR-143/145 in estrogen-deficient bone loss
por: Xu, Rongyao, et al.
Publicado: (2021)

Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines
por: Koo, Sunwoo, et al.
Publicado: (2012)

The Microrna-143/145 Cluster in Tumors: A Matter of Where and When
por: Poli, Valeria, et al.
Publicado: (2020)

MiR-143 and MiR-145 Regulate IGF1R to Suppress Cell Proliferation in Colorectal Cancer
por: Su, Jiaojiao, et al.
Publicado: (2014)

miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6
por: Lei, Chao, et al.
Publicado: (2017)

rs41291957 controls miR‐143 and miR‐145 expression and impacts coronary artery disease risk
por: Hall, Ignacio Fernando, et al.
Publicado: (2021)

Double agents: genes with both oncogenic and tumor-suppressor functions
por: Shen, Libing, et al.
Publicado: (2018)

Identification of miRs-143 and -145 that Is Associated with Bone Metastasis of Prostate Cancer and Involved in the Regulation of EMT
por: Peng, Xinsheng, et al.
Publicado: (2011)

Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis
por: Das, Ani V., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_85o3vqdv2lhuoq69h8qh555v79